The blood-brain barrier -- a network of blood vessels and tissues that nurtures and protects the brain from harmful substances circulating in the blood -- is disrupted in Alzheimer's disease. Now, researchers have uncovered unique molecular signatures of blood-brain barrier dysfunction that could point to new ways to diagnose and treat the disease.